Onco-hypertension: hypertension induced by VEGF pathway inhibition

Cancer therapies are increasingly linked to a wide spectrum of cardiovascular toxicities, presenting significant challenges in the long-term care of oncology patients. Among these, therapy-induced hypertension stands out as one of the most consistent and clinically relevant adverse effects, especial...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nicolas L. Palaskas, Jung Hyun Kim, Silvia Fernanda López Moreno, Bernardo Casso-Chapa, Noah I. Beinart, Nnenne Nnanna, Keila Carolina Ostos Mendoza, Anita Deswal, Syed Wamique Yusuf, Efstratios Koutroumpakis, Jun-ichi Abe, Michael S. Ewer
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-04-01
Serija:	Frontiers in Cardiovascular Medicine
Teme:	blood pressure cancer cardio-oncology hypertension vascular endothelial growth factor
Online dostop:	https://www.frontiersin.org/articles/10.3389/fcvm.2026.1748445/full
Oznake:	Označite Brez oznak, prvi označite!